Accelovance — Washington D.C., District of Columbia

Accelovance is a clinical research site located in Washington D.C., District of Columbia, United States 20006.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Accelovance has participated in 2 clinical trials.

Therapeutic areas: Plague, Bacillus Anthracis (Anthrax).

Sponsors: PharmAthene UK Limited.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Accelovance?

Accelovance has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Accelovance conducted?

Accelovance has 2 clinical trials on record. Their work covers Plague, Bacillus Anthracis (Anthrax).

Is Accelovance accredited by Crixeo Health?

Accelovance has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Accelovance?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.